Cutaneous Leukocytoclastic Vasculitis and Myelodysplastic Syndrome With Little or No Evidence of Associated Autoimmune Disorders-A Case Report and a Brief Review of the Literature

被引:12
作者
Das, Monisha [1 ]
Chhabra, Rajiv [1 ]
Hinton, Stuart W. [2 ]
机构
[1] Univ Missouri, Dept Internal Med, Kansas City, MO 64108 USA
[2] Univ Missouri, Kansas City Canc Ctr, Dept Hematol Oncol, Kansas City, MO 64108 USA
关键词
Cutaneous leukocytoclastic vasculitis; Myelodysplastic syndrome; Seronegative CLV;
D O I
10.1097/MAJ.0b013e31815e8c0b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cutaneous leukocytoclastic vasculitis (CLV) is a necrotizing inflammatory disease of the small vessels in the dermis. Approximately 50% of cases with CLV are primary or idiopathic and the remainder may be associated with various diseases. Less than 1% CLV occurs in association with malignancies including leukemia, lymphoma, and myelodysplastic syndrome (MDS). The pathogenetic mechanism of CLV remains speculative and is generally believed to be related to autoimmune processes. We report here a 77-year-old white woman who presented with contemporaneous occurrence of CLV and MDS (WHO subtype RAEB-2). Autoantibodies and immune-complexes were not detected either in the serum or by direct immunofluorescense in the skin biopsy. The clinical course of MDS remained steady, but the cutaneous lesion resolved within 2 weeks with minimal or no specific therapy except corticosteroids. We suggest that absence of autoimmune phenomena and immune-complex in the skin lesions of CLV may be a hallmark of good prognosis.
引用
收藏
页码:368 / 371
页数:4
相关论文
共 20 条
  • [1] Myelodysplastic syndrome and associated skin lesions: a review of the literature
    Avivi, I
    Rosenbaum, H
    Levy, Y
    Rowe, J
    [J]. LEUKEMIA RESEARCH, 1999, 23 (04) : 323 - 330
  • [2] A comparative review of classification systems in myelodysplastic syndromes (MDS)
    Bennett, JM
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (04) : S3 - S10
  • [3] Cutaneous vasculitis in children and adults -: Associated diseases and etiologic factors in 303 patients
    Blanco, R
    Martínez-Taboada, VM
    Rodríguez-Valverde, V
    García-Fuentes, M
    [J]. MEDICINE, 1998, 77 (06) : 403 - 418
  • [4] DREYFUS B, 1981, NOUV REV FR HEMATOL, V23, P115
  • [5] PARANEOPLASTIC AUTOIMMUNE PHENOMENA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - RESPONSE TO IMMUNOSUPPRESSIVE THERAPY
    ENRIGHT, H
    JACOB, HS
    VERCELLOTTI, G
    HOWE, R
    BELZER, M
    MILLER, W
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 403 - 408
  • [6] Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study
    Giannouli, S
    Voulgarelis, M
    Zintzaras, E
    Tzioufas, AG
    Moutsopoulos, HM
    [J]. RHEUMATOLOGY, 2004, 43 (05) : 626 - 632
  • [7] CUTANEOUS VASCULITIS IN PATIENTS WITH MYELODYSPLASIA
    GREEN, AR
    SHUTTLEWORTH, D
    BOWEN, DT
    BENTLEY, DP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) : 364 - 365
  • [8] International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg, P
    Cox, C
    LeBeau, MM
    Fenaux, P
    Morel, P
    Sanz, G
    Sanz, M
    Vallespi, T
    Hamblin, T
    Oscier, D
    Ohyashiki, K
    Toyama, K
    Aul, C
    Mufti, G
    Bennett, J
    [J]. BLOOD, 1997, 89 (06) : 2079 - 2088
  • [9] Gyselbrecht L, 1996, CLIN EXP RHEUMATOL, V14, P665
  • [10] Hamblin TJ, 1996, SEMIN HEMATOL, V33, P150